Novo Nordisk and AWS Join Forces: Inside the New AI Drug Discovery Pact and London Innovation Hub

Pharmaceutical giant Novo Nordisk has inked a major strategic agreement with Amazon Web Services (AWS) to supercharge AI-driven drug discovery. As part of this powerful collaboration, the two companies are launching a dedicated innovation hub in London. The partnership is designed to harness AWS's immense cloud computing and machine learning infrastructure to drastically accelerate the research and development of next-generation therapeutics, highlighting the growing convergence of massive cloud capabilities and life-saving biotechnology.

https://www.fiercebiotech.com/biotech/novo-nordisk-and-aws-sign-ai-drug-discovery-pact-launch-london-innovation-hub